Zingerone
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Zingerone
Description:
Zingerone (Vanillylacetone) is a nontoxic methoxyphenol isolated from Zingiber officinale, with potent anti-inflammatory, antidiabetic, antilipolytic, antidiarrhoeic, antispasmodic and anti-tumor[3] properties[1]. Zingerone alleviates oxidative stress and inflammation, down-regulates NF-κB mediated signaling pathways[2]. Zingerone acts as an anti-mitotic agent, and inhibits the growth of neuroblastoma cells[3].Product Name Alternative:
Vanillylacetone; GingeroneUNSPSC:
12352005Hazard Statement:
H315, H319, H335Target:
NF-κBType:
Natural ProductsRelated Pathways:
NF-κBApplications:
Cancer-programmed cell deathField of Research:
Cancer; Metabolic Disease; Inflammation/ImmunologyAssay Protocol:
https://www.medchemexpress.com/Zingerone.htmlConcentration:
10mMPurity:
99.79Solubility:
DMSO : 100 mg/mL (ultrasonic)Smiles:
COC1=C (O) C=CC (CCC (C) =O) =C1Molecular Formula:
C11H14O3Molecular Weight:
194.23Precautions:
H315, H319, H335References & Citations:
[1]Ahmad B, et al. A Review on Pharmacological Properties of Zingerone (4- (4-Hydroxy-3-methoxyphenyl) -2-butanone) . ScientificWorldJournal. 2015;2015:816364.|[2]Ahmad B, et al. Zingerone (4- (4-hydroxy-3-methylphenyl) butan-2-one) protects against alloxan-induced diabetes via alleviation of oxidative stress and inflammation: Probable role of NF-kB activation. Saudi Pharm J. 2018 Dec;26 (8) :1137-1145.|[3]Choi JS, et al. Zingerone Suppresses Tumor Development through Decreasing Cyclin D1 Expression and Inducing Mitotic Arrest. Int J Mol Sci. 2018 Sep 19;19 (9) .Shipping Conditions:
Room TemperatureStorage Conditions:
4°C (Powder, sealed storage, away from moisture)Scientific Category:
Natural ProductsClinical Information:
No Development ReportedCAS Number:
122-48-5
